This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nyui, N. Articles by Ishii, M. Search for Related Content PubMed PubMed Citation Articles by Nyui, N. Articles by Ishii, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

(Hypertension. 1997;30:859-867.)
© 1997 American Heart Association, Inc.

Articles

Tissue Angiotensinogen Gene Expression Induced by Lipopolysaccharide in Hypertensive Rats

Nobuo Nyui; Kouichi Tamura; Satoshi Yamaguchi; Masashi Nakamaru; Tomoaki Ishigami; Machiko Yabana; Minoru Kihara; Hisao Ochiai; Naomichi Miyazaki; Satoshi Umemura; ; Masao Ishii

From the Second Department of Internal Medicine, Yokohama City (Japan) University School of Medicine.

Correspondence to Satoshi Umemura, MD, Second Department of Internal Medicine, Yokohama City University School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama 236, Japan.

Abstract There is now convincing evidence that various tissues express their own tissue renin-angiotensin system, which may be regulated independently of the systemic renin-angiotensin system. However, little information is available on the regulation of the tissue renin-angiotensin system. We investigated the regulation of tissue angiotensinogen gene expression with respect to the development of hypertension. We measured basal and lipopolysaccharide-stimulated plasma angiotensinogen concentrations by radioimmunoassay and examined the expression of tissue angiotensinogen by Northern blot analysis in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) at 4 and 13 weeks of age. Basal plasma angiotensinogen concentration in SHR was comparable to that in WKY at 4 weeks of age and was significantly higher than that in WKY at 13 weeks of age. Lipopolysaccharide induced a significant increase in plasma angiotensinogen concentration in both WKY and SHR at 4 and 13 weeks of age. At 4 weeks of age, the basal levels of angiotensinogen mRNA in the liver, fat, adrenal, and aorta were higher in WKY than in SHR. At 13 weeks of age, the basal levels of angiotensinogen mRNA in the fat, adrenal, aorta, spleen, and kidney were higher in WKY than in SHR, while that in the liver did not differ significantly between the two strains. At 4 weeks of age, pretreatment with lipopolysaccharide increased the angiotensinogen mRNA levels in the liver, fat, adrenal, and aorta in both WKY and SHR. At 13 weeks of age, pretreatment with lipopolysaccharide increased the angiotensinogen mRNA levels in the liver, aorta, and adrenal; decreased those in the spleen; and had no effect in the kidney in both WKY and SHR. Interestingly, lipopolysaccharide increased the angiotensinogen mRNA level in fat only in SHR, with no effect in WKY, at 13 weeks of age. Lipopolysaccharide stimulated tumor necrosis factor- mRNA expression in fat of WKY and SHR, and the increase in tumor necrosis factor- mRNA level in SHR was significantly greater than that in WKY. Therefore, the increased tumor necrosis factor- mRNA expression may be involved in the increased lipopolysaccharide-induced expression of angiotensinogen gene in fat of SHR at 13 weeks of age. These data suggest that the transcriptional and probably posttranscriptional regulation of angiotensinogen mRNA differs between SHR and WKY, that the regulation of angiotensinogen gene expression is tissue-specific, and that the altered expression of the angiotensinogen gene may be involved in the development of hypertension.

Key Words: rats, inbred SHR • angiotensinogen • renin-angiotensin system • lipopolysaccharide • RNA, messenger • tumor necrosis factor-

This article has been cited by other articles:

				J. A. Jessup, A. J. Trask, M. C. Chappell, S. Nagata, J. Kato, K. Kitamura, and C. M. Ferrario Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2614 - H2618. [Abstract] [Full Text] [PDF]

				V. Jankowski, R. Vanholder, M. van der Giet, L. Henning, M. Tolle, G. Schonfelder, A. Krakow, S. Karadogan, N. Gustavsson, J. Gobom, et al. Detection of Angiotensin II in Supernatants of Stimulated Mononuclear Leukocytes by Matrix-Assisted Laser Desorption Ionization Time-of-Flight/Time-of-Flight Mass Analysis Hypertension, September 1, 2005; 46(3): 591 - 597. [Abstract] [Full Text] [PDF]

				H. Shimizu, M. Miyoshi, K. Matsumoto, O. Goto, T. Imoto, and T. Watanabe The Effect of Central Injection of Angiotensin-Converting Enzyme Inhibitor and the Angiotensin Type 1 Receptor Antagonist on the Induction by Lipopolysaccharide of Fever and Brain Interleukin-1{beta} Response in Rats J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 865 - 873. [Abstract] [Full Text] [PDF]

				M. Flesch, A. Hoper, L. Dell'Italia, K. Evans, R. Bond, R. Peshock, A. Diwan, T. A. Brinsa, C.-C. Wei, N. Sivasubramanian, et al. Activation and Functional Significance of the Renin-Angiotensin System in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor Circulation, August 5, 2003; 108(5): 598 - 604. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]

				A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF]

				Z. Pausova, B. Deslauriers, D. Gaudet, J. Tremblay, T. A. Kotchen, P. Larochelle, A. W. Cowley, and P. Hamet Role of Tumor Necrosis Factor-{alpha} Gene Locus in Obesity and Obesity-Associated Hypertension in French Canadians Hypertension, July 1, 2000; 36(1): 14 - 19. [Abstract] [Full Text] [PDF]

				S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF]

				B. Zinman, A. J. G. Hanley, S. B. Harris, J. Kwan, and I. G. Fantus Circulating Tumor Necrosis Factor-{alpha} Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 272 - 278. [Abstract] [Full Text]

				K. Tamura, S. Umemura, N. Nyui, K. Hibi, T. Ishigami, M. Kihara, Y. Toya, and M. Ishii Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R1 - R9. [Abstract] [Full Text] [PDF]

				J.-M. Fernandez-Real, B. Lainez, J. Vendrell, M. Rigla, A. Castro, G. Penarroja, M. Broch, A. Perez, C. Richart, P. Engel, et al. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E952 - E959. [Abstract] [Full Text] [PDF]